Form 4: Hagerty Inc. Director Robert Kauffman Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Director Robert Kauffman sold Hagerty, Inc. (HGTY) shares on March 13, 14, and 17, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Robert Kauffman, a director of Hagerty, Inc. (HGTY), reported the sale of Class A Common Stock on March 13, 14, and 17, 2025.
- The sales were executed under a Rule 10b5-1 trading plan adopted on August 9, 2024.
- On March 13, 2025, 2,677 shares were sold at a weighted average price of $9.21.
- On March 14, 2025, 15,238 shares were sold at a weighted average price of $9.33.
- On March 17, 2025, 12,950 shares were sold at a weighted average price of $9.35.
- These transactions reduced Kauffman's direct holdings while his indirect holdings through Aldel LLC decreased to 4,192,996 shares.
- Following the reported transactions, Kauffman directly owns 53,474 shares of Class A Common Stock.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative. While the sales are under a pre-arranged plan, insider selling can create uncertainty among investors.
Negatives
- A director is selling shares, which could be perceived negatively by investors.
Risks
- Continued sales by insiders could put downward pressure on the stock price.
Industry Context
Insider trading activity is always closely watched in the financial industry as it can provide signals, though not always reliable, about a company's prospects. Form 4 filings are a routine part of regulatory compliance for corporate insiders.
Comparison to Industry Standards
- Monitoring insider sales is a common practice when evaluating a company's health.
- Comparing the volume and frequency of insider sales to those of peer companies can provide context.
- For example, if other executives at Hagerty or similar companies like Progressive or Allstate are also selling shares, it could indicate a broader trend or concern.
Stakeholder Impact
- Shareholders may react to the news of insider selling.
- The impact on employees is likely minimal unless the selling signals broader concerns about the company's performance.
Key Dates
| Date | Description |
|---|---|
| 2024-08-09 | Date of adoption of Rule 10b5-1 trading plan. |
| 2025-03-13 | Date of first reported transaction: sale of 2,677 shares. |
| 2025-03-14 | Date of second reported transaction: sale of 15,238 shares. |
| 2025-03-17 | Date of third reported transaction: sale of 12,950 shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.